Ticker
ENTXCompany Name
ENTERA BIO LTDSector
HealthcareIndustry
BiotechnologyExchange
NASDAQDate | Total Assets | Cash and Equivalents | Cash to Assets Ratio |
---|---|---|---|
6/30/2025 | $ 19.67M | $ 18.87M | 95.96% |
3/31/2025 | $ 21.6M | $ 20.57M | 95.25% |
12/31/2024 | $ 9.39M | $ 8.66M | 92.23% |
9/30/2024 | $ 7.74M | $ 6.92M | 89.33% |
6/30/2024 | $ 10.04M | $ 9.06M | 90.24% |
3/31/2024 | $ 10.24M | $ 9.19M | 89.75% |
12/31/2023 | $ 11.77M | $ 11.02M | 93.66% |
9/30/2023 | $ 8.56M | $ 7.58M | 88.56% |
6/30/2023 | $ 10.45M | $ 9.13M | 87.46% |
3/31/2023 | $ 11.61M | $ 10.69M | 92.12% |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
CashnEq / Assets
(=) Cash to Assets
Cash to Assets for ENTERA BIO LTD is calculated as follows: CashnEq [ $ 7.07M ] / Assets [ $ 8.78M ]
(=) Cash to Assets [ 80.5% ]
Minimum
Sep 30, 2020
Maximum
Jun 30, 2025
Average
Median
filtered constituents | 3.94K |
---|---|
min | 0% |
max | 40.71% |
average | 9.76% |
median | 6.41% |
std | 9.51% |